Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avantis U.S. Equity ETF (NY:AVUS)

108.08 +0.47 (+0.44%)
Streaming Delayed Price Updated: 1:44 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 78,363
Open 108.04
Bid (Size) 108.07 (4)
Ask (Size) 108.10 (7)
Prev. Close 107.61
Today's Range 107.92 - 108.23
52wk Range 79.20 - 108.05
Shares Outstanding 822,300
Dividend Yield 1.14%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IonQ Stock Stokes Retail Optimism After Receiving Necessary Clearances For Oxford Ionics Acquisition: Retail Sees ‘Multitrillion Dollar Market Company’
Via Stocktwits
VF Corp To Sell Dickies Brand To Bluestar Alliance For $600M
Via Stocktwits

Performance

YTD
+11.6%
+11.6%
1 Month
+2.9%
+2.9%
3 Month
+9.8%
+9.8%
6 Month
+15.5%
+15.5%
1 Year
+16.1%
+16.1%

More News

Read More
GE Vernova To Sell Proficy Software Unit To TPG For $600M
Via Stocktwits
Delta CEO Says Consumer Confidence Recovers From ‘Big Impact’ Earlier This Year: Report
Via Stocktwits
Ford Draws Retail Investor Concerns After It Recalls Nearly 1.5M Vehicles In US Over Rear View Camera Display Issues
Via Stocktwits
Topics Product Recall
Regeneron Says Experimental Therapy Reduced Symptoms Of Cat, Birch Allergies In Late-Stage Trials
Via Stocktwits
Halliburton Reduces Workforce As Costs Rise Amid Lower Oil Prices: Report
Via Stocktwits
This Pharma Stock Soared 36% Today And Drew Price Target Hikes From Wall Street – More Details Inside
Via Stocktwits
Lucid Stock Gets A Price Target Cut From Stifel As It Gears Up For A Reverse Stock Split: Retail Sees 50% Dive Post Split
Via Stocktwits
Regeneron Stock Rallies After Therapy For Autoimmune Disease Meets Late-Stage Trial Goals: Retail Thinks Stock Might Hit An All-Time Low Soon
Via Stocktwits
Vanda Pharma Stock Rockets 9% After Federal Appeals Court Sets Aside FDA Action: Retail Expects Stock To Cross $5-Mark
Via Stocktwits
Ford Issues Nearly 356,000 Vehicles Recall In U.S., But Retail Investors Spot Emerging Catalysts
Via Stocktwits
Topics Electric Vehicles
Medtronic Appoints New Directors After Elliott Becomes Major Investor: Company Hikes FY26 Guidance After Q1 Beat
Via Stocktwits
Lyft Has A ‘Steady Path Forward’ According To UBS: Retail Thinks Stock Is Undervalued
Via Stocktwits
This Aviation Stock Has Doubled In 2025, Surged Over 200% In 12 Months, And Is Trending On Friday – Do You Own It?
Via Stocktwits
This Stock Has Tumbled 50% In One Year, Gets A Price Target Cut Today – But Retail Believes $400-450 Is A Good Entry Point
Via Stocktwits
Cigna Stock Slides 8% On Thursday But Wells Fargo Analyst Is Surprised: Here’s What Happened
Via Stocktwits
Humana Stock Gains On Upbeat Earnings And Raised Guidance, Drawing Retail Praise And UnitedHealth Contrasts
Via Stocktwits
Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’
Via Stocktwits
Rivian Plans Shut Down Of Illinois Plant For Three Weeks, R2 Hopes Sparks Mixed Reactions Among Retail Investors
Via Stocktwits
Pfizer In Talks With Trump Administration Regarding Lower Drug Prices And Tariffs, Says CEO: Stock Rallies On Improved Full-Year Guidance, Upbeat Q2 Report
Via Stocktwits
Topics Government
BioCryst Eyes Strengthening Pipeline After Upbeat Q2 Earnings: Retail Thinks Fair Valuation For Stock Is Double The Current Level
Via Stocktwits
Topics Artificial Intelligence Earnings
Ford US Sales Rise 9.3% In July: Retail Gets Curious About August 11 Revelation
Via Stocktwits
Topics Earnings Electric Vehicles World Trade
CVS Health CFO Says Company Maintaining Prudent View On Medical Cost Trends Through Remainder Of Year
Via Stocktwits
Topics Artificial Intelligence Earnings Workforce
Lucid Signs Up Timothée Chalamet As Global Brand Ambassador: Retail Terms It A Desperate Cash-Draining Move
Via Stocktwits

Frequently Asked Questions

Is Avantis U.S. Equity ETF publicly traded?
Yes, Avantis U.S. Equity ETF is publicly traded.
What exchange does Avantis U.S. Equity ETF trade on?
Avantis U.S. Equity ETF trades on the New York Stock Exchange
What is the ticker symbol for Avantis U.S. Equity ETF?
The ticker symbol for Avantis U.S. Equity ETF is AVUS on the New York Stock Exchange
What is the current price of Avantis U.S. Equity ETF?
The current price of Avantis U.S. Equity ETF is 108.08
When was Avantis U.S. Equity ETF last traded?
The last trade of Avantis U.S. Equity ETF was at 09/15/25 01:44 PM ET
What is the market capitalization of Avantis U.S. Equity ETF?
The market capitalization of Avantis U.S. Equity ETF is 88.87M
How many shares of Avantis U.S. Equity ETF are outstanding?
Avantis U.S. Equity ETF has 89M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.